Skip to content
TheBrief.Health

Living with EGFR-variant non-small cell lung cancer

Stories from people navigating EGFR-variant non-small cell lung cancer — diagnosis, treatment, caregiving, and the ordinary days in between.

1 story

Lung cancer pathology slide beside a molecular testing report and oncology treatment notes.

Oncology

Ivonescimab Extends Survival in EGFR-Variant NSCLC

Ivonescimab plus chemotherapy prolonged median overall survival after EGFR-TKI therapy, but toxicity, generalizability and US regulatory status shape its relevance.

Rayan Salih · September 14, 2026 · 7 min

Other conditions

One story a day

The story of the day, in your inbox

One health journey each morning — no advice, no alarm, just company for the road.